Trending News

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Sabin Begins Marburg Vaccine Trial in U.S.
Posted On Wednesday, April 16, 2025
Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
Posted On Wednesday, April 16, 2025
Oncotelic Therapeutics Reports FY 2024 Highlights and FY 2024 Earnings Compared to FY 2023
Posted On Wednesday, April 16, 2025
Biomerica Announces Reverse Stock Split
Posted On Wednesday, April 16, 2025
GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
Posted On Wednesday, April 16, 2025
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
Posted On Wednesday, April 16, 2025
Conduit Pharmaceuticals Announces Leadership Changes
Posted On Wednesday, April 16, 2025
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
Posted On Wednesday, April 16, 2025
PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting
Posted On Wednesday, April 16, 2025
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
Posted On Wednesday, April 16, 2025
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
Posted On Wednesday, April 16, 2025
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
Posted On Wednesday, April 16, 2025
Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
Posted On Wednesday, April 16, 2025
Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
Posted On Wednesday, April 16, 2025
OncoC4 Selected to Present at the 2025 AACR Meeting's Showcase Session
Posted On Wednesday, April 16, 2025
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
Posted On Wednesday, April 16, 2025
Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union
Posted On Tuesday, April 15, 2025
Raw Garden Launches Blockbuster Deals for 4/20 Across California
Posted On Tuesday, April 15, 2025
Theratechnologies Provides Update on Sale Process
Posted On Tuesday, April 15, 2025
Radiance Announces First Patient Dosing in Phase 1 Clinical Trial of its Next Generation ROR-1 Targeted ADC for Hematologic and Solid Malignancies
Posted On Tuesday, April 15, 2025
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, April 15, 2025
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
Posted On Tuesday, April 15, 2025
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
Posted On Tuesday, April 15, 2025
Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
Posted On Tuesday, April 15, 2025
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Posted On Tuesday, April 15, 2025

Print